Expressions and significances of Fas/FasL and Bcl-2 in placentae of cases with preeclampsia
Gong Hu
Abstract
Gong Hu
Abstract
Objective:To explore the changes of expressions of Fas antigen(Fas) and its ligand(FasL),Bcl-2 in syncytiotrophoblast of placentae of pregnant women with preeclampsia and their significances. Methods:Immunohistochemical SP method was used to detect the expression levels of Fas,FasL and Bcl-2 in placental tissues of 20 normal late pregnant women(normal late pregnancy group),20 pregnant women with mild preeclampsia(mild preeclampsia group) and 20 pregnant women with severe preeclampsia(severe preeclampsia group). Results:Fas,FasL and Bcl-2 mainly expressed in cytoplasm and cell membrane of placental syncytiotrophoblast.The expression levels of FasL and Bcl-2 in mild preeclampsia group and severe preeclampsia group were(62.28±4.92),(80.67±6.19) and(41.74±6.38),(64.42±5.43),respectively,which were significantly lower than those in normal late pregnancy group((80.72±6.01),(92.49±7.88))(P0.01).The expression levels of Fas in mild preeclampsia group and severe preeclampsia group were(55.94±4.35) and(75.98±6.01),respectively,which were significantly higher than that in normal late pregnancy group(40.58±5.43)(P0.01). Conclusion:The unbalance of Fas,FasL and Bcl-2 expressions in placental syncytiotrophoblast of pregnant women with preeclampsia may be related to the occurrence and development of preeclampsia.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the changes of expressions of Fas antigen(Fas) and its ligand(FasL),Bcl-2 in syncytiotrophoblast of placentae of pregnant women with preeclampsia and their significances. Methods:Immunohistochemical SP method was used to detect the expression levels of Fas,FasL and Bcl-2 in placental tissues of 20 normal late pregnant women(normal late pregnancy group),20 pregnant women with mild preeclampsia(mild preeclampsia group) and 20 pregnant women with severe preeclampsia(severe preeclampsia group). Results:Fas,FasL and Bcl-2 mainly expressed in cytoplasm and cell membrane of placental syncytiotrophoblast.The expression levels of FasL and Bcl-2 in mild preeclampsia group and severe preeclampsia group were(62.28±4.92),(80.67±6.19) and(41.74±6.38),(64.42±5.43),respectively,which were significantly lower than those in normal late pregnancy group((80.72±6.01),(92.49±7.88))(P0.01).The expression levels of Fas in mild preeclampsia group and severe preeclampsia group were(55.94±4.35) and(75.98±6.01),respectively,which were significantly higher than that in normal late pregnancy group(40.58±5.43)(P0.01). Conclusion:The unbalance of Fas,FasL and Bcl-2 expressions in placental syncytiotrophoblast of pregnant women with preeclampsia may be related to the occurrence and development of preeclampsia.
Key concepts: Syncytiotrophoblast, Preeclampsia, Fas ligand, Medicine, Pregnancy, Immunohistochemistry, Placenta, Obstetrics